RPG
NMTR

Risk Paradigm Group’s 9 Meters Biopharma NMTR Stock Holding History

Risk Paradigm Group’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-50
Closed -$27.4K – 215
2018
Q1 		$27.4K Sell
50
-85
-63% -$16.5K 0.03% 169
2017
Q4 		$16.5K Hold
135
– – 0.02% 230
2017
Q3 		$18.9K Buy
+135
New +$21.1K 0.02% 199

Other funds holding NMTR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Risk Paradigm Group's NMTR Position: Q2 2018 in Review

Risk Paradigm Group sold out of 9 Meters Biopharma (NMTR) in Q2 2018, closing a stake of 50 shares — an estimated $27.4K sold.

Risk Paradigm Group first reported a position in NMTR in Q3 2017 and held it in 3 quarters. The position peaked at $27.4K in Q1 2018. 36 funds tracked by Wall St. Rank hold NMTR as of Q2 2018.

  • Risk Paradigm Group reported no remaining 9 Meters Biopharma position as of Q2 2018 after selling out during the quarter.
  • Risk Paradigm Group sold 50 9 Meters Biopharma shares in Q2 2018, an estimated $27.4K.
  • Risk Paradigm Group first reported a position in 9 Meters Biopharma in Q3 2017 and held it in 3 quarters.
  • Risk Paradigm Group's 9 Meters Biopharma position peaked at $27.4K in Q1 2018.
  • 36 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2018.

Based on Risk Paradigm Group's 13F filing for Q2 2018, filed 10 Aug 2018.